Breaking News - The Fly

Open Search

BLTE

Belite Bio

$

()

Belite Bio announces PMDA submission of Tinlarebant for trial in Japan

BLTE

3/22/2024 - 08:02am

Belite Bio reports Q4 EPS (27c), consensus (30c)

BLTE

3/12/2024 - 05:15am

Belite Bio reports Q4 EPS (27c), consensus (30c)

BLTE

3/11/2024 - 21:33pm

Belite Bio participates in a conference call with Benchmark

BLTE

2/27/2024 - 10:25am

Belite Bio participates in a conference call with Benchmark

BLTE

2/27/2024 - 04:55am

Belite Bio participates in a conference call with Benchmark

BLTE

2/21/2024 - 16:04pm

Belite Bio receives approval for Phase 3 geographic atrophy trial in China

BLTE

12/27/2023 - 11:47am

Belite Bio initiated with bullish view at Maxim

BLTE

12/14/2023 - 07:26am

Belite Bio reports Q3 EPS (40c), consensus (32c)

BLTE

11/13/2023 - 20:17pm

Belite Bio participates in a conference call with Cantor Fitzgerald

BLTE

11/9/2023 - 11:25am

Belite Bio participates in a conference call with Cantor Fitzgerald

BLTE

11/9/2023 - 04:55am

Belite Bio price target raised to $59 from $55 at H.C. Wainwright

BLTE

11/6/2023 - 08:49am

Belite Bio presents results from a 24-month, Phase 2 study of Tinlarebant

BLTE

11/6/2023 - 08:20am

Belite Bio participates in a conference call with Cantor Fitzgerald

BLTE

11/2/2023 - 16:20pm

Belite Bio reports Q2 EPS (26c), consensus (30c)

BLTE

8/9/2023 - 05:38am